PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2004The FASEB Journal96 citationsOpen Access

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

View Full Paper
CTCarsten TschöpeTWThomas WaltherJKJens Koniger

Structured PICO

P
Population
Male Sprague-Dawley (SD) rats and transgenic rats (TGR) expressing the human kallikrein 1 (hKLK1) gene in streptozotocin (STZ)-induced diabetic conditions (n=10/group)
I
Intervention
Transgenic expression of the human kallikrein 1 (hKLK1) gene
C
Comparator
Wild-type Sprague-Dawley (SD) rats with STZ-induced diabetes and normoglycemic controls
O
Outcome
Left ventricular function and cardiac fibrosis (total collagen content and expression of types I, III, and VI collagen) at 6 weekssurrogate

Transgenic expression of human tissue kallikrein prevents left ventricular dysfunction and cardiac fibrosis in a rat model of diabetic cardiomyopathy via a bradykinin B2 receptor-dependent pathway.

Abstract

ABSTRACT Diabetic cardiomyopathy includes fibrosis. Kallikrein (KLK) can inhibit collagen synthesis and promote collagen breakdown. We investigated cardiac fibrosis and left ventricular (LV) function in transgenic rats (TGR) expressing the human kallikrein 1 (hKLK1) gene in streptozotocin (STZ) ‐induced diabetic conditions. Six weeks after STZ injection, LV function was determined in male Sprague‐Dawley (SD) rats and TGR(hKLK1) ( n =10/group) by a Millar tip catheter. Total collagen content (Sirius Red staining) and expression of types I, III, and VI collagen were quantified by digital image analysis. SD‐STZ hearts demonstrated significantly higher total collagen amounts than normoglycemic controls, reflected by the concomitant increment of collagen types I, III, and VI. This correlated with a significant reduction of LV function vs. normoglycemic controls. In contrast, surface‐specific content of the extracellular matrix, including collagen types I, III, and VI expression, was significantly lower in TGR(hKLK1)‐STZ, not exceeding the content of SD and TGR(hKLK1) controls. This was paralleled by a preserved LV function in TGR(hKLK1)‐STZ animals. The kallikrein inhibitor aprotinin and the bradykinin (BK) B2 receptor antagonist icatibant reduced the beneficial effects on LV function and collagen content in TGR(hKLK1)‐STZ animals. Transgenic expression of hKLKl counteracts the progression of LV contractile dysfunction and extracellular matrix remodeling in STZ‐induced diabetic cardiomyopathy via a BK B2 receptor‐dependent pathway.—Tschope, C., Walther, T., Königer, J., Spillmann, F., Westermann, D., Escher, F., Pauschinger, M., Pesquero, J. B., Bader, M., Schultheiss, H.‐P., Noutsias, M. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J. 18, 828–835 (2004)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tschöpe et al. (2004) studied this question.

synapsesocial.com/papers/6a729e54ac440176ef2ac41ahttps://doi.org/10.1096/fj.03-0736com
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Collagen remodelling in myocardia of patients with diabetes.1993 · 247 citations
  2. 2Bradykinin-Induced Reductions in Collagen Gene Expression Involve Prostacyclin1998 · 64 citations
  3. 3Matrix Metalloproteinases2002 · 729 citations
  4. 4Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene2000 · 110 citations
  5. 5Multiple Interactions Between the Renin-Angiotensin and the Kallikrein-Kinin Systems: Role of ACE Inhibition and AT1 Receptor Blockade2002 · 124 citations